Insights into the pathogenesis of vein graft disease: Lessons from intravascular ultrasound

Cardiovascular Ultrasound

Volumn 2, Issue , 2004, Pages

  Murphy, Gavin J ^a   Angelini, Gianni D ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Coronary artery bypass grafting; Intravascular ultrasound; Saphenous vein graft

Indexed keywords

ACETYLSALICYLIC ACID; PACLITAXEL; RAPAMYCIN; THAPSIGARGIN;

ANGIOGRAPHY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL OCCLUSION; BLOOD VESSEL WALL; CARDIOVASCULAR RISK; CELL ACTIVITY; CELL PROLIFERATION; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE COURSE; EVALUATION; EXPERIMENT; EXTRACELLULAR MATRIX; GRAFT FAILURE; GRAFT PATENCY; HEMODYNAMICS; HUMAN; IMPLANTATION; INTRAVASCULAR ULTRASOUND; MEDICAL RESEARCH; PATHOGENESIS; POSTOPERATIVE PERIOD; RESTENOSIS; REVIEW; RISK FACTOR; SAPHENOUS VEIN; SAPHENOUS VEIN GRAFT; VEIN GRAFT;

CLINICAL TRIALS AS TOPIC; CORONARY ARTERY BYPASS; GRAFT OCCLUSION, VASCULAR; GRAFT REJECTION; HUMANS; PROGNOSIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR PATENCY; VEINS;

EID: 5044227738     PISSN: 14767120     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-7120-2-8     Document Type: Review

References (55)

1. Motwani JG, Topol EJ: Aortocoronary saphenous vein graft disease. Pathogenesis, predisposition and prevention. Circulation 1998, 97:916-931.
2. Bourassa MG, Campeau L, Lespérance J, Grondin CM: Changes in grafts and coronary arteries after saphenous vein aortocoronary bypass surgery: results at repeat angiography. Circulation 1982, 65:90-97.
3. Rosenfeldt FL, Guo-Wei H, Buxton BF, Angus JA: Pharmacology of Coronary Artery Bypass Grafts. Ann Thorac Surg 1999, 67:878-888.
4. Angelini GD, Jeremy JY: Towards the treatment of vein bypass graft failure - a perspective of the Bristol Heart Institute. Biorheology 2002, 39:491-499.
5. Lie JT, Lawrie GM, Morris G: Aortocoronary bypass saphenous vein graft atherosclerosis. Am J Cardiol 1997, 40:907-914.
6. Atkinson JB, Forman MB, Vaughn WK, Robinowitz M, Mcallister HA, Virmani R: Morphologic changes in long-term saphenous vein bypass grafts. Chest 1985, 88:341-348.
7. Izzat MB, West RR, Bryan AJ, Angelini GD: Coronary artery bypass surgery: Current practise in the United Kingdom. Br Heart J 1994, 71:382-385.
8. Hoffman SN, TenBrook JA, Wolf MP, et al.: A meta-analysis ofrandomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 2003, 41:1293-1304.
9. Park SJ, Shim WH, Ho DS, et al.: A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003, 348:1537-1545.
10. Regar E, Serruys PW, Bode C, et al.: Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation 2002, 106:1949-1956.
11. Lemos PA, Serruys PW, van Domburg RT, et al.: Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004, 109:190-195.
12. Campeau L, Hunninghake DB, Knatterud GL, et al.: Aggressivecholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators. Circulation 1999, 99:3241-3247.
13. Nase-Hueppmeier S, Uebis R, Doerr R, Hanrath P: Intravascular ultrasound to assess aortocoronary venous bypass grafts in vivo. Am J Cardiol 1992, 70:455-458.
14. Hozumi T, Yoshikawa J, Yoshida K, et al.: Use of intravascular ultrasound for in vivo assessment of changes in intimal thickness of angiographically normal saphenous vein grafts one year after aortocoronary bypass surgery. Heart 1996, 76:317-320.
15. Nissen SE, Yock P: Intravascular Ultrasound. Novel Pathophysiological Insights and Current Clinical Applications. Circulation 2001, 103:604-616.
16. Higuchi Y, Hirayama A, Shimizu M, Sakakibara T, Kodama K: Postoperative changes in angiographically normal saphenous vein coronary bypass grafts using intravascular ultrasound. Heart Vessels 2002, 17:57-60.
17. Willard JE, Netto D, Demian SE, et al.: Intravascular ultrasound imaging of saphenous vein grafts in vitro: comparison with histologic andquantitative angiographic findings. J Am Coll Cardiol 1992, 19:759-764.
18. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis G: Compensatory enlargement of human atherosclerotic coronary arteries:. N Engl J Med 1987, 316:1371-1375.
19. Ward MR, Pasterkamp G, Yeung AC, Borst C: Arterial Remodeling; Mechanisms and Clinical Implications. Circulation 2000, 102:1186-1191.
20. Nishioka T, Luo H, Berglund H, Eigler NL, Kim C-J, Tabak SW, Siegel RJ: Absence of focal compensatory enlargement or constriction in diseased human coronary saphenous vein bypass grafts: an intravascular ultrasound study. Circulation 1996, 93:683-690.
21. Ge J, Liu F, Bhate R, et al.: Does remodeling occur in the diseased human saphenous vein bypass grafts? An intravascular ultrasound study. Int J Card Imag 1999, 15:295-300.
22. Hong M, Mintz GS, Hong MK, et al.: Intravascular ultrasound assessment of the presence of vascular remodelling in diseased human saphenous bypass grafts. Am J Cardiol 1999, 84:992-998.
23. Kobayashi T, Makuuchi H, Naruse Y, et al.: Assessment of saphenous vein graft wall characteristics with intravascular ultrasound imaging. Jpn J Thorac Cardiovasc Surg 1998, 46:701-706.
24. Yamada T, Itoh T, Nakano S, Tokunaga O: Time-dependent thickening of the intima in aortocoronary saphenous vein grafts: clinicopathological analysis of 24 patients. Heart Vessels 1995, 10:41-45.
25. Angelini GD, Bryan AJ, Williams HMJ, Mortgan R, Newby AC: Distension promotes platelet and leucocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg 1990, 99:433-439.
26. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A: Adventitial remodeling following coronary arterial injury. Circulation 1996, 93:340-348.
27. Shi Y, O'Brien JE Jr, Fard A, Mannion JD, Wang D, Zalewski A: Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996, 94:1655-1664.
28. Bassiouny HS, Song RH, Hong XF, Singh A, Kocharyan H, Glagov S: Flow regulation of 72-kD collagenase IV (MMP-2) after experimental arterial injury. Circulation 1998, 98:157-163.
29. Wentzel JJ, Kloet J, Andhyiswara I, Oomen JA, Schuurbiers JC, de Smet BJ, Post MJ, de Kleijn D, Pasterkamp G, Borst C, Slager CJ, Krams R: Shear-stress and wall-stress regulation of vascular remodeling after balloon angioplasty: effect of matrix metalloproteinase inhibition. Circulation 2001, 104:91-96.
30. Kenagy RD, Vergel S, Mattsson E, Bendeck M, Reidy MA, Clowes AW: The role of plasminogen, plasminogen activators, and matrix metalloproteinases in primate arterial smooth muscle cell migration. Arterioscler Thromb Vasc Biol 1996, 16:1373-1382.
31. Goetzl EJ, Banda MJ, Leppert D: Matrix metalloproteinases in immunity. J Immunol 1996, 156:1-4.
32. Schwartz SM, deBlois D, O'Brien ERM: The intima: soil for atherosclerosis and restenosis. Circ Res 1995, 77:445-465.
33. Camejo G, Lopez A, Lopez F, Quinones J: Interaction of low density lipoproteins with arterial proteoglycans: the role of charge and sialic acid content. Atherosclerosis 1985, 55:93-105.
34. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS: Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocytes/macrophages. Arterioscler Thromb 1992, 12:237-249.
35. Gabbiani G, Ryan GB, Majno G: Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971, 27:549-550.
36. Shi Y, O'Brien J, Fard A, Mannion JD, Wang D, Zalewski A: Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996, 94:1655-1664.
37. Zalewski A, Shi Y: Vascular Myofibroblasts: Lessons From Coronary Repair and Remodeling. Arterioscler Thromb Vasc Biol 1997, 17:417-422.
38. Mendelsohn FO, Foster GP, Palacios IF, Weyman AE, Weissman NJ: In vivo assessment by intravascular ultrasound of enlargement in saphenous vein bypass graft. Am J Cardiol 1995, 76:1066-1069.
39. Gussenhoven EJ, Geselschap JH, van Lankeren W, Posthuma DJ, van der Lugt A: Remodeling of atherosclerotic coronary arteries assessed with intravascular ultrasound in vitro. Am J Cardiol 1997, 79:699-702.
40. Nishioka T, Luo H, Eigler N, Berglund H, Kim CJ, Siegel RT: Contribution of inadequate compensatory enlargement to development of human coronary artery stenosis, an in vivo intravascular ultrasound study. J Am Coll Cardiol 1996, 27:1571-1576.
41. Hermiller JB, Tenaglia AN, Kisslo KB, et al.: In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol 1993, 71:665-668.
42. Kornowski R, Mintz GS, Lansky AJ, et al.: Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am J Cardiol 1998, 81:1298-1304.
43. Tauth J, Pinnow E, Sullebarger JT, et al.: Predictors of coronary arterial remodeling patterns in patients with myocardial ischemia. Am J Cardiol 1997, 80:1352-1355.
44. Lerman A, Cannan CR, Higano SH, et al.: Coronary vascular remodeling in association with endothelial dysfunction. Am J Cardiol 1998, 81:1105-1109.
45. Wensing PJ, Meiss L, Mali WP, et al.: Early atherosclerotic lesions spiraling through the femoral artery. Arterioscler Thromb Vasc Biol 1998, 18:1554-1558.
46. Berglund H, Luo H, Nishioka T, et al.: Highly localized arterial remodeling in patients with coronary atherosclerosis: an intravascular ultrasound study. Circulation 1997, 96:1470-1476.
47. Libby P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372.
48. Schachner T, Zou Y, Oberhuber A: Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg 2004, 77:1580-1585.
49. Shukla N, Angelini GD, Ascione R, Talpahewa S, Capoun R, Jeremy JY: Nitric oxide-donating aspirins: novel drugs for the treatment of Saphenous vein graft failure. Ann Thorac Surg 2002, 75:1437-1442.
50. Wan S, Yim AP, Johnson JL, Shukla N, Angelini GD, Smith FC, Dashwood MR, Jeremy JY: The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts. J Thorac Cardiovasc Surg 2004, 127:1317-1322.
51. Izzat MB, Mehta D, Bryan AJ, Reeves B, Newby AC, Angelini GD: Influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting. Circulation 1996, 94:1741-1745.
52. Mann MJ, Whittemore AD, Donaldson MC, et al.: Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet 1999, 354:1493-498.
53. Cavender JB, Rogers WJ, Fisher LD, Gersh BJ, Coggin CJ, Myers WO: Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10 year follow-up. J Am Coll Cardiol 1992, 20:287-294.
54. Voors AA, van Brussel BL, Plokker T, et al.: Smoking and cardiac events after venous coronary bypass surgery: a 15-year follow-up study. Circulation 1996, 93:42-44.
55. The Post Coronary Artery Bypass Graft Trial Investigators: The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 1997, 336:153-162.